These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 31658631

  • 41. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
    Tomašič T, Katsamakas S, Hodnik Ž, Ilaš J, Brvar M, Solmajer T, Montalvão S, Tammela P, Banjanac M, Ergović G, Anderluh M, Peterlin Mašič L, Kikelj D.
    J Med Chem; 2015 Jul 23; 58(14):5501-21. PubMed ID: 26098163
    [Abstract] [Full Text] [Related]

  • 42. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
    Gjorgjieva M, Tomašič T, Barančokova M, Katsamakas S, Ilaš J, Tammela P, Peterlin Mašič L, Kikelj D.
    J Med Chem; 2016 Oct 13; 59(19):8941-8954. PubMed ID: 27541007
    [Abstract] [Full Text] [Related]

  • 43. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
    Ibrahim NM, Fahim SH, Hassan M, Farag AE, Georgey HH.
    Eur J Med Chem; 2022 Jan 15; 228():114021. PubMed ID: 34871841
    [Abstract] [Full Text] [Related]

  • 44. Design, synthesis and biological evaluation of novel Pseudomonas aeruginosa DNA gyrase B inhibitors.
    Jogula S, Krishna VS, Meda N, Balraju V, Sriram D.
    Bioorg Chem; 2020 Jul 15; 100():103905. PubMed ID: 32388436
    [Abstract] [Full Text] [Related]

  • 45. Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria.
    Sanabria-Ríos DJ, Rivera-Torres Y, Rosario J, Gutierrez R, Torres-García Y, Montano N, Ortíz-Soto G, Ríos-Olivares E, Rodríguez JW, Carballeira NM.
    Bioorg Med Chem Lett; 2015 Nov 15; 25(22):5067-71. PubMed ID: 26483137
    [Abstract] [Full Text] [Related]

  • 46. Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols.
    Priyanka, Singh V, Ekta, Katiyar D.
    Bioorg Chem; 2017 Apr 15; 71():120-127. PubMed ID: 28196603
    [Abstract] [Full Text] [Related]

  • 47. Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents.
    Li Y, Bionda N, Fleeman R, Wang H, Ozawa A, Houghten RA, Shaw L.
    Bioorg Med Chem; 2016 Nov 01; 24(21):5633-5638. PubMed ID: 27663549
    [Abstract] [Full Text] [Related]

  • 48. New pyrrole derivatives as DNA gyrase and 14α-demethylase inhibitors: Design, synthesis, antimicrobial evaluation, and molecular docking.
    Hilmy KMH, Kishk FNM, Shahen EBA, Sobh EA, Hawata MA.
    Drug Dev Res; 2023 Sep 01; 84(6):1204-1230. PubMed ID: 37165799
    [Abstract] [Full Text] [Related]

  • 49. Selenophene-containing inhibitors of type IIA bacterial topoisomerases.
    Wiles JA, Phadke AS, Bradbury BJ, Pucci MJ, Thanassi JA, Deshpande M.
    J Med Chem; 2011 May 12; 54(9):3418-25. PubMed ID: 21443219
    [Abstract] [Full Text] [Related]

  • 50. New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase.
    Zidar N, Tomašič T, Macut H, Sirc A, Brvar M, Montalvão S, Tammela P, Ilaš J, Kikelj D.
    Eur J Med Chem; 2016 Jul 19; 117():197-211. PubMed ID: 27100032
    [Abstract] [Full Text] [Related]

  • 51. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
    Jakopin Ž, Ilaš J, Barančoková M, Brvar M, Tammela P, Sollner Dolenc M, Tomašič T, Kikelj D.
    Eur J Med Chem; 2017 Apr 21; 130():171-184. PubMed ID: 28246042
    [Abstract] [Full Text] [Related]

  • 52. Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors.
    Tomašič T, Barančoková M, Zidar N, Ilaš J, Tammela P, Kikelj D.
    Arch Pharm (Weinheim); 2018 Jan 21; 351(1):. PubMed ID: 29239018
    [Abstract] [Full Text] [Related]

  • 53. Synthesis, Identification, Computer-Aided Docking Studies, and ADMET Prediction of Novel Benzimidazo-1,2,3-triazole Based Molecules as Potential Antimicrobial Agents.
    Rashdan HRM, Abdelmonsef AH, Abou-Krisha MM, Yousef TA.
    Molecules; 2021 Nov 25; 26(23):. PubMed ID: 34885701
    [Abstract] [Full Text] [Related]

  • 54. Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors.
    Nastasă C, Vodnar DC, Ionuţ I, Stana A, Benedec D, Tamaian R, Oniga O, Tiperciuc B.
    Int J Mol Sci; 2018 Jan 11; 19(1):. PubMed ID: 29324679
    [Abstract] [Full Text] [Related]

  • 55. Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin-1,2,4-triazole scaffolds.
    Pathak P, Novak J, Shukla PK, Grishina M, Potemkin V, Verma A.
    Arch Pharm (Weinheim); 2021 Jun 11; 354(6):e2000473. PubMed ID: 33656194
    [Abstract] [Full Text] [Related]

  • 56. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
    Khan T, Sankhe K, Suvarna V, Sherje A, Patel K, Dravyakar B.
    Biomed Pharmacother; 2018 Jul 11; 103():923-938. PubMed ID: 29710509
    [Abstract] [Full Text] [Related]

  • 57. Synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives: Antimicrobial activity, DNA Gyrase inhibition and molecular docking.
    Abd El-Aleam RH, George RF, Hassan GS, Abdel-Rahman HM.
    Bioorg Chem; 2020 Jan 11; 94():103411. PubMed ID: 31711767
    [Abstract] [Full Text] [Related]

  • 58. Synthesis and Biological Evaluation of New Pyridothienopyrimidine Derivatives as Antibacterial Agents and Escherichia coli Topoisomerase II Inhibitors.
    Mohi El-Deen EM, Abd El-Meguid EA, Karam EA, Nossier ES, Ahmed MF.
    Antibiotics (Basel); 2020 Oct 14; 9(10):. PubMed ID: 33066400
    [Abstract] [Full Text] [Related]

  • 59. Design and synthesis of novel 1H-tetrazol-5-amine based potent antimicrobial agents: DNA topoisomerase IV and gyrase affinity evaluation supported by molecular docking studies.
    Szulczyk D, Dobrowolski MA, Roszkowski P, Bielenica A, Stefańska J, Koliński M, Kmiecik S, Jóźwiak M, Wrzosek M, Olejarz W, Struga M.
    Eur J Med Chem; 2018 Aug 05; 156():631-640. PubMed ID: 30031974
    [Abstract] [Full Text] [Related]

  • 60. Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies.
    Ammar YA, Farag AA, Ali AM, Hessein SA, Askar AA, Fayed EA, Elsisi DM, Ragab A.
    Bioorg Chem; 2020 Jun 05; 99():103841. PubMed ID: 32325335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.